Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report

Fig. 1

Serial positron emission tomography with integrated computed tomography images showing response to lung metastases before and after pembrolizumzb treatment, interruption and rechallenge during and after anti-tuberculosis (TB) therapy. a Multiple bilateral lung metastases before pembrolizumab treatment. b Marked reduction in size and number of lung metastases after pembrolizumab treatment. c Enlarging lung metastases after pembrolizumab interruption due to TB reactivation. d Tumour shrinkage after re-challenge with pembrolizumab

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us